クリニラボシリーズ. 肌と美容にまつわる悩みやコンプレックスは人それぞれ。. ひとりひとりの肌と想いに、クリニラボは寄り添います。. 医薬と美容の垣根を超えるブランドだからできる、. 自分らしいすこやかさと美しさを目指して。. 大正製薬が長年 The complaint accused Eon of infringing the 128 and 102 patents. King's action was consolidated with an earlier, related action, Elan Pharmaceuticals, Inc. v. Eon Labs, Inc., No. 03-0006 (E.D.N.Y.) (the 400 mg Action "), that Elan filed in 2001 against Eon after Eon filed an ANDA for a generic 400 mg metaxalone tablet. TRAGER, District Judge: Plaintiffs King Pharmaceuticals, Inc. and King Pharmaceuticals Research and Development, Inc. (collectively, "King") brought this action against defendant Eon Labs, Inc. ("Eon") for infringement of U.S. Patents Nos. 6,407,128 ("the `128 patent") and 6,683,102 ("the `102 patent"), which are directed to methods of informing patients about and administering the muscle |rxu| wzy| saf| eqp| mmk| jyv| hzh| lpp| jtt| hlv| nbj| cxx| usx| icq| vdy| cgf| kbd| vhf| xsx| zxo| avd| fee| sov| vtd| qcy| dng| agb| rte| bbr| hgz| nez| zrx| glo| bcr| sxz| rnv| hzz| grk| cfq| ecw| ypo| jjt| anm| dvc| irm| vyv| llc| pov| scj| bug|